Articles, Research, & Resources

Resources

Recommended Research

Dakwar, E., Levin, F., Hart, C. L., Basaraba, C., Choi, J., Pavlicova, M., & Nunes, E. V. (2020). A Single Ketamine Infusion Combined With Motivational Enhancement Therapy for Alcohol Use Disorder: A Randomized Midazolam-Controlled Pilot Trial. The American journal of psychiatry, 177(2), 125–133. https://doi.org/10.1176/appi.ajp.2019.19070684
Dakwar, E., Nunes, E. V., Hart, C. L., Foltin, R. W., Mathew, S. J., Carpenter, K. M., Choi, C., Basaraba, C. N., Pavlicova, M., & Levin, F. R. (2019). A Single Ketamine Infusion Combined With Mindfulness-Based Behavioral Modification to Treat Cocaine Dependence: A Randomized Clinical Trial. The American journal of psychiatry, 176(11), 923–930. https://doi.org/10.1176/appi.ajp.2019.18101123
Dakwar, E., Nunes, E. V., Hart, C. L., Hu, M. C., Foltin, R. W., & Levin, F. R. (2018). A sub-set of psychoactive effects may be critical to the behavioral impact of ketamine on cocaine use disorder: Results from a randomized, controlled laboratory study. Neuropharmacology, 142, 270–276. https://doi.org/10.1016/j.neuropharm.2018.01.005
Dore, J., Turnipseed, B., Dwyer, S., Turnipseed, A., Andries, J., Ascani, G., Monnette, C., Huidekoper, A., Strauss, N., & Wolfson, P. (2019). Ketamine Assisted Psychotherapy (KAP): Patient Demographics, Clinical Data and Outcomes in Three Large Practices Administering Ketamine with Psychotherapy. Journal of psychoactive drugs, 51(2), 189–198. https://doi.org/10.1080/02791072.2019.1587556
Feder, A., Costi, S., Rutter, S. B., Collins, A. B., Govindarajulu, U., Jha, M. K., Horn, S. R., Kautz, M., Corniquel, M., Collins, K. A., Bevilacqua, L., Glasgow, A. M., Brallier, J., Pietrzak, R. H., Murrough, J. W., & Charney, D. S. (2021). A Randomized Controlled Trial of Repeated Ketamine Administration for Chronic Posttraumatic Stress Disorder. The American journal of psychiatry, 178(2), 193–202. https://doi.org/10.1176/appi.ajp.2020.20050596
Ivan Ezquerra-Romano, I., Lawn, W., Krupitsky, E., & Morgan, C. (2018). Ketamine for the treatment of addiction: Evidence and potential mechanisms. Neuropharmacology, 142, 72–82. https://doi.org/10.1016/j.neuropharm.2018.01.017
Zarate, C. A., Jr, Singh, J. B., Carlson, P. J., Brutsche, N. E., Ameli, R., Luckenbaugh, D. A., Charney, D. S., & Manji, H. K. (2006). A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Archives of general psychiatry, 63(8), 856–864. https://doi.org/10.1001/archpsyc.63.8.856

Experts in the Field

We are grateful for the shared knowledge, education, and mentorship we’ve received from the following organizations.

California Institute of Integral Studies

Center for Psychedelic & Consciousness Research

Fluence

The Integrative Psychiatry Institute

Internal Family Systems Institute

The Ketamine Training Center

Multidisciplinary Association for Psychedelic Studies (MAPS)

Polaris Insight Center

PROTEA

Transdisciplinary Center for Research in Psychoactive Substances

Usona Institute

Resources

Recommended Articles, Videos, & Podcasts

Recommended Research

Experts in the Field